Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK / STAT3 signaling pathway-Reference-Cited by-同舟云学术

Apatinib weakens resistance of gastric cancer cells to paclitaxel by suppressing JAK / STAT3 signaling pathway

Published:2021-08-18 Issue: Volume: Page:
ISSN:0272-4391
Container-title:Drug Development Research
language:en
Short-container-title:Drug Dev Res

Author:

Bei Yanping¹,Chen Xue¹,Xu Quan¹,Lv Jiaming¹,Hu Jing¹,Yang Shaohui²^ORCID

Affiliation:

1. Department of Radiotherapy Ningbo Medical Center Lihuili Hospital Ningbo China

2. Department of Anorectal Surgery Ningbo Medical Center Lihuili Hospital Ningbo China

Publisher

Wiley

Subject

Drug Discovery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ddr.21867

Reference35 articles.

1. Pregabalin and lacosamide ameliorate paclitaxel-induced peripheral neuropathy via inhibition of JAK/STAT signaling pathway and Notch-1 receptor

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway

4. Synergistic interaction between tetra‐arsenic oxide and paclitaxel in human cancer cells in vitro;Chung W. H.;International Journal of Oncology,2009

5. Apatinib exerts anti-tumour effects on ovarian cancer cells

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclanoline Reverses Cisplatin Resistance in Bladder Cancer Cells by Inhibiting the JAK2/STAT3 Pathway;Anti-Cancer Agents in Medicinal Chemistry;2024-11

2. A Novel Online Nomogram Established with Five Features before Surgical Resection for Predicating Prognosis of Neuroblastoma Children: A Population-Based Study;Technology in Cancer Research & Treatment;2023-01

3. High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study;Technology in Cancer Research & Treatment;2023-01

4. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway–Related Prognostic Prediction Model in Gastric Cancer;Frontiers in Genetics;2022-07-19